Evidence map›Paper›PMID 35233284›Full record

ArticleClinical kidney journal2022

Circulating Omentin-1 levels and altered iron balance in chronic haemodialysis patients.

Davide Bolignano, Evangelia Dounousi, Pierangela Presta, Marta Greco, Anila Duni, Giuseppina Crugliano, Charalambos Pappas, Ethymios Pappas, Francesco Dragone, Lampros Lakkas and 3 more

Open access · goldAbstract read
In one paragraph

Article in Clinical kidney journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Davide BolignanoNephrology and Dialysis Unit, Magna Graecia University, Catanzaro, Italy.ORCID https://orcid.org/0000-0003-3032-245X
Evangelia DounousiDepartment of Nephrology, University Hospital of Ioannina, Ioannina, Greece.
Pierangela PrestaNephrology and Dialysis Unit, Magna Graecia University, Catanzaro, Italy.
Marta GrecoClinical Pathology Lab, Magna Graecia University, Catanzaro, Italy.
Anila DuniDepartment of Nephrology, University Hospital of Ioannina, Ioannina, Greece.
Giuseppina CruglianoNephrology and Dialysis Unit, Magna Graecia University, Catanzaro, Italy.
Charalambos PappasDepartment of Nephrology, University Hospital of Ioannina, Ioannina, Greece.
Ethymios PappasHemodialysis Unit, General Hospital of Filiates, Filiates, Greece.
Francesco DragoneClinical Pathology Lab, Magna Graecia University, Catanzaro, Italy.
Lampros LakkasSecond Department of Cardiology, University Hospital of Ioannina, Ioannina, Greece.
Daniela Patrizia FotiClinical Pathology Lab, Magna Graecia University, Catanzaro, Italy.
Michele AndreucciNephrology and Dialysis Unit, Magna Graecia University, Catanzaro, Italy.
Giuseppe CoppolinoNephrology and Dialysis Unit, Magna Graecia University, Catanzaro, Italy.
Magna Graecia University · ITUniversity Hospital of Ioannina · GRGeneral Hospital of Filiates · GRUniversity of Ioannina · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIron deficiency is highly prevalent among patients undergoing chronic haemodialysis (HD) but its correct identification is often problematic as common biomarkers of iron status, such as transferrin saturation (TSAT) and ferritin, can be altered by inflammation or malnutrition.

methodsIn this pilot multicentre study, we aimed at evaluating circulating levels of Omentin-1, a novel fat depot-specific adipokine that is also involved in iron regulation, in a cohort of 85 chronic HD patients with relation to their iron status.

resultsOmentin-1 levels in HD were statistically higher than in healthy controls (P = 0.03) and there was a significant, growing trend in all iron parameters across Omentin-1 tertiles (P < 0.001). Compared with patients with optimal iron status, Omentin-1 levels were lower in subjects categorized according to TSAT ≤20% or serum ferritin ≤200 μg/L (both P < 0.001) and even more reduced in 19 patients (22%) simultaneously displaying low levels of both markers (P < 0.001). In this latter group, Omentin-1 levels increased in parallel to all other iron markers after iron correction by i.v. supplementation. At multivariate regression analyses, ferritin (β = 0.71; P < 0.001) and TSAT (β = 0.32; P = 0.03) remained the sole independent predictors of Omentin-1 levels. This biomarker also showed a remarkable diagnostic capacity at receiver operating characteristic analyses in identifying iron-depleted HD patients according to a criterion of TSAT ≤20% [area under the curve (AUC) 0.827], ferritin ≤200 μg/L (AUC 0.863) or low levels of both parameters (AUC 0.907).

conclusionsFindings obtained indicate that Omentin-1 is somewhat involved in iron balance regulation and might be a candidate biomarker for diagnosing and managing altered iron conditions in HD patients.

Indexed as

ferritinhaemodialysisironOmentin-1TSAT

Identifiers

PMID35233284
PMCPMC8874876
OpenAlexW3207548789

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.